Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 166

1.

Increased GABAergic function in mouse models of Huntington's disease: reversal by BDNF.

Cepeda C, Starling AJ, Wu N, Nguyen OK, Uzgil B, Soda T, André VM, Ariano MA, Levine MS.

J Neurosci Res. 2004 Dec 15;78(6):855-67.

PMID:
15505789
2.

Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.

Klapstein GJ, Fisher RS, Zanjani H, Cepeda C, Jokel ES, Chesselet MF, Levine MS.

J Neurophysiol. 2001 Dec;86(6):2667-77.

3.

Transient and progressive electrophysiological alterations in the corticostriatal pathway in a mouse model of Huntington's disease.

Cepeda C, Hurst RS, Calvert CR, Hernández-Echeagaray E, Nguyen OK, Jocoy E, Christian LJ, Ariano MA, Levine MS.

J Neurosci. 2003 Feb 1;23(3):961-9.

4.

Postsynaptic action of BDNF on GABAergic synaptic transmission in the superficial layers of the mouse superior colliculus.

Henneberger C, Jüttner R, Rothe T, Grantyn R.

J Neurophysiol. 2002 Aug;88(2):595-603.

5.

Striatal potassium channel dysfunction in Huntington's disease transgenic mice.

Ariano MA, Cepeda C, Calvert CR, Flores-Hernández J, Hernández-Echeagaray E, Klapstein GJ, Chandler SH, Aronin N, DiFiglia M, Levine MS.

J Neurophysiol. 2005 May;93(5):2565-74. Epub 2004 Dec 29.

6.
7.

Differential electrophysiological properties of dopamine D1 and D2 receptor-containing striatal medium-sized spiny neurons.

Cepeda C, André VM, Yamazaki I, Wu N, Kleiman-Weiner M, Levine MS.

Eur J Neurosci. 2008 Feb;27(3):671-82. doi: 10.1111/j.1460-9568.2008.06038.x.

PMID:
18279319
8.

Altered balance of glutamatergic/GABAergic synaptic input and associated changes in dendrite morphology after BDNF expression in BDNF-deficient hippocampal neurons.

Singh B, Henneberger C, Betances D, Arevalo MA, Rodríguez-Tébar A, Meier JC, Grantyn R.

J Neurosci. 2006 Jul 5;26(27):7189-200.

9.

Reduced activity of cortico-striatal fibres in the R6/2 mouse model of Huntington's disease.

Traficante A, Riozzi B, Cannella M, Rampello L, Squitieri F, Battaglia G.

Neuroreport. 2007 Dec 3;18(18):1997-2000.

PMID:
18007201
10.

Abnormal sensitivity to cannabinoid receptor stimulation might contribute to altered gamma-aminobutyric acid transmission in the striatum of R6/2 Huntington's disease mice.

Centonze D, Rossi S, Prosperetti C, Tscherter A, Bernardi G, Maccarrone M, Calabresi P.

Biol Psychiatry. 2005 Jun 15;57(12):1583-9.

PMID:
15953496
11.

Altered cortical glutamate receptor function in the R6/2 model of Huntington's disease.

André VM, Cepeda C, Venegas A, Gomez Y, Levine MS.

J Neurophysiol. 2006 Apr;95(4):2108-19. Epub 2005 Dec 28.

13.

Role of GABA transporter 3 in GABAergic synaptic transmission at striatal output neurons.

Kirmse K, Kirischuk S, Grantyn R.

Synapse. 2009 Oct;63(10):921-9. doi: 10.1002/syn.20675.

PMID:
19588470
15.

Reduced striatal acetylcholine efflux in the R6/2 mouse model of Huntington's disease: an examination of the role of altered inhibitory and excitatory mechanisms.

Farrar AM, Callahan JW, Abercrombie ED.

Exp Neurol. 2011 Dec;232(2):119-25. doi: 10.1016/j.expneurol.2011.08.010. Epub 2011 Aug 16.

PMID:
21864528
16.

Action-potential-independent GABAergic tone mediated by nicotinic stimulation of immature striatal miniature synaptic transmission.

Liu Z, Otsu Y, Vasuta C, Nawa H, Murphy TH.

J Neurophysiol. 2007 Aug;98(2):581-93. Epub 2007 Jun 6.

17.

Brain-derived neurotrophic factor upregulates and maintains AMPA receptor currents in neocortical GABAergic neurons.

Nagano T, Yanagawa Y, Obata K, Narisawa-Saito M, Namba H, Otsu Y, Takei N, Nawa H.

Mol Cell Neurosci. 2003 Oct;24(2):340-56.

PMID:
14572457
18.

Retrograde suppression of GABAergic currents in a subset of SCN neurons.

Gompf HS, Irwin RP, Allen CN.

Eur J Neurosci. 2006 Jun;23(12):3209-16.

PMID:
16820011
19.

The role of adenosine A2a receptors in regulating GABAergic synaptic transmission in striatal medium spiny neurons.

Mori A, Shindou T, Ichimura M, Nonaka H, Kase H.

J Neurosci. 1996 Jan 15;16(2):605-11.

20.

Expression profiling of Huntington's disease models suggests that brain-derived neurotrophic factor depletion plays a major role in striatal degeneration.

Strand AD, Baquet ZC, Aragaki AK, Holmans P, Yang L, Cleren C, Beal MF, Jones L, Kooperberg C, Olson JM, Jones KR.

J Neurosci. 2007 Oct 24;27(43):11758-68.

Supplemental Content

Support Center